Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases.
Yana VinogradovaTom DeningJulia Hippisley-CoxLauren TaylorMichael MooreCarol CouplandPublished in: BMJ (Clinical research ed.) (2021)
This study gives estimates for risks of developing dementia and Alzheimer's disease in women exposed to different types of menopausal hormone therapy for different durations and has shown no increased risks of developing dementia overall. It has shown a slightly increased risk of developing Alzheimer's disease among long term users of oestrogen-progestogen therapies.